King Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 491.4 | 672.6 | 465.6 |
| Net Investing Cash Flow | (156.1) | (776.3) | (436.3) |
| Net Financing Cash Flow | 584.9 | 9.8 | 54.5 |
| Net Change in Cash | 920.2 | (93.8) | 83.8 |
| Depreciation & Amortization | 150.7 | 173.9 | 147.5 |
| Capital Expenditures | (57.5) | (49.6) | (45.8) |
| Cash Dividends Paid | -- | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
